Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cell-Building Discovery Could Reduce Need for Some Animal Research

By LabMedica International staff writers
Posted on 23 Feb 2009
Biomedical engineers, using a three-dimensional (3D) Petri dish they invented, have successfully built complex-shaped microtissues by assembling small building blocks of living cell clusters. More...
This new development should help advance the field of tissue engineering and could reduce the need for some animal research.

The Brown University (Providence, RI, USA) team, led by Brown professor Dr. Jeffrey Morgan, successfully used clusters of cells to build microtissues of more complex shapes. Such a finding, detailed in the March 1, 2009, issue of Biotechnology and Bioengineering and posted at the end of January 2009 on the journal's Website, has enormous implications for basic cell biology, drug discovery and tissue research, according to Dr. Morgan.

Because the tissues Dr. Morgan's team created in the laboratory are more like natural tissue, they can be constructed to have complicated lace-like patterns similar to a vasculature, the arrangement of blood vessels in the body or in an organ. According to Dr. Morgan, that added complexity could ultimately reduce the need to use animals in specific kinds of research. "There is a need for...tissue models that more closely mimic natural tissue already inside the body in terms of function and architecture,” said Dr. Morgan, a Brown professor of medical science and engineering. "This shows we can control the size, shape, and position of cells within these 3D structures.”

But according to Dr. Morgan, this development also makes a significant contribution to the field of tissue engineering and regenerative medicine. "We think this is one step toward using building blocks to build complex-shaped tissues that might one day be transplanted,” he said.

The new finding builds on earlier research by Dr. Morgan and a team of Brown students, which appeared in September 2007 in the journal Tissue Engineering. The earlier study highlighted the invention of a 3D Petri dish about the size of a peanut-butter cup and made of agarose, a complex carbohydrate derived from seaweed with the consistency of Jell-O (a gelatin dessert). Dr. Morgan and students in his lab developed the dish, creating a product where cells do not adhere to the surface. Instead, the cells self-assemble naturally and form "microtissues.”

For the new study, Dr. Morgan and coworkers made 3D microtissues in one 3D Petri dish, harvested these living building blocks and then added them to more complex 3D molds shaped either like a honeycomb, with holes, or a donut with a hole in the middle. Those skin cells fused with liver cells in the more complex molds and formed even larger microstructures. Researchers found that the molds helped control the shape of the final microtissue. They also found that they could control the rate of fusion of the cells by aging them for a longer or shorter time before they were harvested. The longer the wait, Dr. Morgan discovered, the slower the process.

Related Links:

Brown University



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.